February 21, 2012 ? Nucletron, an Elekta company, announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) granted Shonin approval to market the microSelectron Digital (HDR-V3) afterloader in Japan.
Designed for precise and targeted treatment of cancer, the microSelectron Digital (HDR-V3) offers reliability in afterloading and has the world’s largest installed base. The scalable and upgradable platform, with 6, 18 or 30 channels, meets the needs of many brachytherapy patients and healthcare professionals.
Nucletron brachytherapy solutions treat cancer from the “inside out,” with the radiation source positioned directly inside or next to the tumor. This form of radiation has proven to be a highly effective treatment option, while also reducing the risk of unintended damage to healthy tissues and organs – reducing potential side effects for patients.
For more information: www.elekta.com
July 11, 2024 
